Director or Officer Departures, Elections, Appointments, and Compensation Arrangements

Business Context and Reporting Period

This Form 8-K Current Report is filed by National Healthcare Properties, Inc. on November 18, 2025. The filing primarily addresses significant changes in executive leadership, specifically the appointment of a new Chief Financial Officer (CFO) and the simultaneous resignation of the incumbent CFO.

Key Financial Metrics

This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.

  • Preferred Stock: The company has two classes of preferred stock registered on the Nasdaq Global Market: 7.375% Series A (NHPAP) and 7.125% Series B (NHPBP).
  • Compensation Metrics (New CFO):
    • Annual Base Salary: $400,000
    • Target Annual Bonus: $350,000
    • 2026 Long-Term Incentive Target Value: No less than $600,000
    • One-Time Restricted Stock Award: $200,000 (vesting over 3 years)

Material Changes

The filing reports the following material changes in corporate governance and personnel effective November 18, 2025:

  • Appointment: Andrew T. Babin was appointed as Chief Financial Officer and Treasurer. He previously served as Head of Financial Strategy and Investor Relations for Medical Properties Trust, Inc.
  • Resignation: Scott M. Lappetito resigned as Chief Financial Officer and Treasurer. The resignation was not due to any disagreement with the Company regarding management, operations, or financial matters.
  • Severance Arrangement: Mr. Lappetito received a separation package including a cash severance equal to his 2025 base salary plus target bonus, full vesting of time-based equity, and 18 months of COBRA health benefits.

Outlook, Risks, and Contingencies

Management Commentary: The filing confirms the transition of financial leadership is complete as of the report date. No specific financial guidance or outlook for future periods is provided in this document.

Risks and Contingencies:

  • Executive Retention: The new CFO's employment agreement includes specific severance provisions. In the event of termination without Cause outside a Change in Control, Mr. Babin is entitled to 1.0x base salary over 24 months and partial equity acceleration. During a Change in Control, this increases to 2.0x (salary + target bonus) paid in a lump sum with full equity acceleration.
  • Restrictive Covenants: Both the new and former CFOs are subject to non-competition, non-solicitation, and confidentiality covenants.

Investor Verification Checklist

  • Verify the exact terms of the Employment Agreement (Exhibit 10.1) regarding performance metrics for the target bonus and long-term incentives.
  • Review the Separation Agreement (Exhibit 10.2) to confirm the total cash outflow associated with Mr. Lappetito's departure.
  • Monitor upcoming quarterly filings (10-Q/10-K) to assess the impact of the leadership transition on financial reporting and capital markets activities.
  • Confirm the vesting schedule and fair value assumptions for the $200,000 one-time equity award granted to Mr. Babin.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.